Table 1.
Study population (patients with data that died during study)
| Characteristic | Number of subjects (n = 182) |
|---|---|
| Age | |
| Median | 73 yr |
| (range) | (28–98 yr) |
| Sex | |
| Female | 105 (58%) |
| Male | 77 (42%) |
| Ethnicity | |
| Asian/Asian British | 1 (0.5%) |
| Black/Black British | 1 (0.5%) |
| White | 168 (92.5%) |
| Mixed | 2 (1.0%) |
| Not stated | 10 (5.5%) |
| Cancer diagnosis | |
| Breast | 15 (8.0%) |
| Endocrine | 5 (3.0%) |
| Gastrointestinal | 60 (33.0%) |
| Gynaecology | 16 (9.0%) |
| Haematology | 11 (6.0%) |
| Head & neck | 4 (2.0%) |
| Lung | 25 (13.5%) |
| Neurology | 7 (4.0%) |
| Skin | 8 (4.5%) |
| Unknown | 10 (5.5%) |
| Urology | 15 (8.0%) |
| Other | 6 (3.5%) |
| Co-morbidities | |
| Cardiac | 62 (34.0%) |
| Gastrointestinal | 32 (17.5%) |
| Neurological | 29 (16.0%) |
| Renal | 19 (10.5%) |
| Respiratory | 35 (19.0%) |